Custom cell line development as a documentation project rather than a cloning project: how cho cell line development toward a stable cho cell line, mammalian cell line development and microbial cell line development diverge on host, timeline and what a regulator will later ask, what a stable cell line service delivers beyond stable cell lines that grow, where custom cloning ends and line development begins, why a cas9 stable cell line is banked like any other production line, what a master cell bank, a working cell bank, a gmp cell bank and the cell line bank record that ties them together each are for, what master cell bank testing must cover before anything downstream is worth doing, how cell bank storage is split so a freezer failure is survivable, and why cell line stability testing at the end of production is the result that decides whether the line was ever fit for purpose

Running the project

1. Choose the host from the molecule, not from habit. Mammalian hosts give human like glycosylation and are the default for complex secreted proteins and antibodies. Microbial hosts give speed and cost for proteins that fold without those modifications. The wrong host is recoverable only by starting again, so the decision belongs before any construct is built.
2. Fix the selection and screening funnel in advance. Agree how many clones enter screening, on what criteria they are ranked, and how many go forward. Titre alone is a poor ranking: growth profile, product quality and behaviour at the intended scale matter as much, and a clone that wins on titre in a plate frequently loses in a bioreactor.
3. Demonstrate clonality in a way someone can check. A single cell origin has to be evidenced, not asserted. Imaging at deposition, a documented limiting dilution with statistics, or both, is what the record needs. This is the item most often missing when a line arrives from a partner and the most expensive to reconstruct.
4. Build the bank structure before you need it. One master bank, working banks drawn from it, and physical separation between storage locations. Decide the vial counts against the projected campaign schedule, and decide them once, because a bank that runs out forces a new bank and a new comparability exercise.
5. Test the bank to a written panel. Identity, viability, recovery, sterility, mycoplasma and adventitious agent testing as the product type demands, with the panel agreed before the vials are filled. Testing after the fact against a panel nobody wrote is how a bank becomes unusable.
6. Run stability to the limit of the intended process. Culture the line past the generation count any campaign would reach and show that expression and product quality hold. A line stable through ten passages and failing at forty is a line you will discover at the worst possible moment.

Mammalian and microbial projects are not the same project

A mammalian development programme spends its time on clone screening and stability because expression is distributed across a heterogeneous pool and only a minority of clones are both productive and durable. A microbial programme spends its time on expression conditions, solubility and downstream recovery, because the organism grows fast and the difficulty moves to the protein rather than the cell.

That difference changes the shape of the quotation. A mammalian proposal that does not describe the screening funnel, or a microbial proposal that does not describe the expression optimisation, is describing half the work.

The bank is the asset, not the clone

Once a project ends, what you own is a set of vials and a file. The clone in the incubator will be discarded. If the vials are not distributed across separate storage, monitored and documented, a single equipment failure removes the entire output of a multi month programme.

Split the master bank across at least two physically separate locations with independent power and alarms, and keep the certificate, the testing panel and the passage history with the inventory record rather than in someone's project folder.

What to insist on in a contract

Ownership of the line and of any intermediate constructs. Delivery of raw screening data rather than a summary. The full testing panel and its results. The passage history. Any licence obligations attached to the host or to an editing technology used along the way.

The last of those catches people out. Host lines and editing tools frequently carry commercial terms that follow the cell line into your own process, and the time to discover them is before the project starts.

Common questions

How long does a mammalian cell line project take?

Realistically several months from construct to a banked, characterised line, with screening and stability consuming most of it. Compressed timelines usually compress the stability work, which is the part that protects you later.

What makes a cell bank a GMP bank?

Manufacture under a quality system, with controlled materials, documented procedures, defined release testing and retained records, rather than any property of the cells. The same clone can be banked at research grade and at GMP grade, and the difference is entirely in the documentation and the environment.

Why is clonality evidence so important?

Because a heterogeneous population drifts, and a drifting population invalidates everything measured against it. Regulators and partners ask how single cell origin was demonstrated, and an answer of limiting dilution alone is increasingly treated as insufficient without supporting evidence.

Does an edited line need different banking?

It needs the same banking plus evidence about the edit: on target confirmation, characterisation of the insertion or disruption, and an assessment of off target effects proportionate to the use. The banking structure itself does not change.

Browse by service class

• Compare Gene synthesis on advertised prices